XEIA Venture Partners | The startups building Human 3

The startups accelerating Human 3

Our portfolio companies combine life sciences, AI, hardware, software, deep tech & health tech in novel ways that often defy conventional categorization

*Denotes investment made outside of XEIA's core funds

Coherence Treating brain cancer with neuromodulation Clinical

Kadence Enhancing male sexual performance Clinical

Lykos MDMA assisted therapy for PTSD Clinical

Mindstate Precision designed altered states of consciousness Clinical

Synchron*The most advanced minimally-invasive BCI Clinical

Beond World's most effective addiction recovery Commercial

Biosphere*Unleashing industrial biology Commercial

Tara Mind Psychedelic therapy as an employee benefit Commercial

Aperture Genetic medicine for neurodegeneration Preclinical

Forecast Building better brain drugs via astrocyte insights Preclinical

Freedom Better Ketamine therapies Preclinical

Kerna Labs Foundation models for better genetic medicines Preclinical

Motif Ending depression with brain-computer interfaces Preclinical

NeuroBionics 10x less invasive brain-computer interfaces Preclinical

Pangea AI engine uncovering nature's hidden cures Preclinical

TippingPoint Epigenetic medicine for brain cancer Preclinical

Ultra Bionics Novel neuromodulation technology Preclinical

Vonova Transvascular brain payload delivery Preclinical

Xylo Psychedelics without the hallucination Preclinical

Stealth Genetic medicine for rare neurological disorders Preclinical

Stealth Why repair when you could replace?Preclinical

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

Thank you! You've been added to our mailing list.

Oops! Something went wrong while submitting the form.

Human 3 manifesto News & content Portfolio Podcast Jobs